( NYSE:CVD )

News from Covance Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 04, 2015, 07:30 ET Covance Reports Fourth Quarter Net Revenue Of $634 Million, Pro Forma EPS Of $0.97 And Record Adjusted Net Orders Of $823 Million

 Covance Inc. (NYSE: CVD) today reported results for its fourth quarter ended December 31, 2014. Net revenue was $634 million, representing...


Jan 20, 2015, 08:30 ET Covance Launches New Solution to Bridge Preclinical to Clinical Development

Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company, today announced the introduction of...


Jan 12, 2015, 09:00 ET Covance Sets February 18, 2015 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Labcorp

 Covance Inc. (NYSE: CVD) today announced it has set a date for a special meeting of its stockholders to consider and vote on the previously...


Nov 03, 2014, 06:05 ET Covance Reports Third Quarter Net Revenue Growth of 3.4% to $627 Million, Pro Forma EPS Growth of 18.2% to $0.98 and Adjusted Net Orders of $752 Million

 Covance Inc. (NYSE: CVD) today reported results for its third quarter ended September 30, 2014.  Net revenue was $627 million,...


Oct 08, 2014, 16:15 ET Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2014 Financial Results Conference Call

 In conjunction with its third quarter 2014 earnings release (expected to be issued after market close on November 3, 2014), Covance Inc....


Sep 07, 2014, 12:00 ET Covance To Present At The Morgan Stanley Global Healthcare Conference

 Covance Inc. (NYSE: CVD) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9, 2014...


Jul 30, 2014, 07:17 ET Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference Call

 In conjunction with its second quarter 2014 earnings release (expected to be issued after market close on July 29, 2014), Covance Inc. (NYSE:...


Jul 29, 2014, 16:01 ET Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million

 Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2014.  Net revenue was $639 million, representing...


Jul 02, 2014, 12:00 ET Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference Call

 In conjunction with its second quarter 2014 earnings release (expected to be issued after market close on July 29, 2014), Covance Inc. (NYSE:...


Jun 09, 2014, 08:00 ET Covance To Present At The William Blair 34th Annual Growth Stock Conference

Covance Inc. (NYSE: CVD) today announced that it will present at the William Blair 34th Annual Growth Stock Conference on Wednesday, June 11, 2014...


Jun 08, 2014, 12:00 ET Covance To Present At The Goldman Sachs 35th Annual Global Healthcare Conference

 Covance Inc. (NYSE: CVD) today announced that it will present at the Goldman Sachs 35th Annual Global Healthcare Conference on Tuesday, June...


May 19, 2014, 09:46 ET Covance Acquires Medaxial

Covance (NYSE: CVD), one of the world's largest and most comprehensive drug development services companies, today announced it has acquired...


May 18, 2014, 16:00 ET Covance to Present at the UBS Global Healthcare Conference

 Covance Inc. (NYSE: CVD) today announced that it will present at the UBS Global Healthcare Conference on Tuesday, May 20, 2014 at 10:00 a.m....


May 12, 2014, 16:01 ET Covance To Present At The Bank Of America Merrill Lynch Health Care Conference

 Covance Inc. (NYSE: CVD) today announced that it will present at the Bank of America Merrill Lynch Health Care Conference on Wednesday, May...


May 05, 2014, 16:01 ET Covance to Present at The Baird 2014 Growth Stock Conference

 Covance Inc. (NYSE: CVD) today announced that it will present at The Baird 2014 Growth Stock Conference on Wednesday, May 7, 2014 at 9:35 a.m....


May 01, 2014, 16:02 ET Covance Reports First Quarter Net Revenue Growth Of 6.9% To $620 Million, Pro Forma EPS Growth Of 20.1% To $0.90 And Adjusted Net Orders Of $710 Million

 Covance Inc. (NYSE: CVD) today reported results for its first quarter ended March 31, 2014.  Net revenue was $620 million, representing...


May 01, 2014, 16:02 ET Covance Launches New Brand: Solutions Made Real™

 Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company, today announced its new brand, Solutions Made RealTM. This...


Feb 11, 2014, 17:57 ET Covance to Present at the Leerink Swann 2014 Global Healthcare Conference

Covance Inc. (NYSE: CVD) today announced that it will present at the Leerink Swann 2014 Global Healthcare Conference on Thursday, February 13, 2014...


Feb 04, 2014, 16:02 ET Covance Reports Fourth Quarter Net Revenue Of $623 Million, Pro Forma EPS Of $0.87 And Adjusted Net Orders Of $769 Million

 Covance Inc. (NYSE: CVD) today reported results for its fourth quarter and year ended December 31, 2013. Net revenue in the fourth quarter was...


Jan 12, 2014, 15:00 ET Covance to Present at the 32nd Annual J. P. Morgan Healthcare Conference

 Covance Inc. (NYSE: CVD) today announced that it will present at the 32nd Annual J. P. Morgan Healthcare Conference on Tuesday, January 14,...


Jan 02, 2014, 16:32 ET Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2013 Financial Results Conference Call

 In conjunction with its fourth quarter 2013 earnings release (expected to be issued after market close on February 4, 2014), Covance Inc....


Dec 19, 2013, 16:15 ET Covance Board Authorizes $100 Million Stock Buyback

 Covance Inc. (NYSE: CVD) said today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common...


Nov 18, 2013, 07:00 ET Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials

 Covance Inc. (NYSE: CVD), one of the world's largest and most comprehensive drug development services companies, and NeoGenomics, Inc....


Nov 11, 2013, 09:42 ET Covance To Present At The Credit Suisse Healthcare Conference

 Covance Inc. (NYSE: CVD) today announced that it will present at the Credit Suisse Healthcare Conference on Wednesday, November 13, 2013 at...


Oct 29, 2013, 16:01 ET Covance Reports Third Quarter Net Revenue Of $607 Million, Pro Forma EPS Of $0.83 And Adjusted Net Orders Of $732 Million

 Covance Inc. (NYSE: CVD) today reported results for its third quarter ended September 30, 2013.  Net revenue was $606.7 million,...